| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2024―Apr―04 |
nCoV-19 therapeutics using cucurbitacin I structural derivatives: an in silico approach |
Ram Lal Swagat Shrestha, Bishnu Prasad Marasini, Jhashanath Adhikari Subin |
| 2 |
[GO] |
2023―Dez―11 |
GC-MS and ADME profile analysis of Carcinoscorpius rotundicauda bioactive compounds and their potential as COVID-19 antiviral |
Ahmad Misbakhus Sururi, Dwi Anggorowati Rahayu, Martina Kurnia Rohma, Maftukhatul Faizah, Elsa Aulia Vebianawati, Mia Savita |
| 3 |
[GO] |
2023―Okt―23 |
Rapid and validated UHPLC method for simultaneous determination of sofosbuvir, ledipasvir and paracetamol as commonly repurposed drugs for COVID-19 treatment: application in spiked human plasma |
Sherif Gamal, Gehad G. Mohamed, Said A. Salih, Menna I. Ezzeldin, Asmaa A. Mandour |
| 4 |
[GO] |
2023―Aug―16 |
Simultaneous spectrophotometric determination of recombined sofosbuvir, ledipasvir and paracetamol together as commonly repurposed drugs for COVID-19 treatment |
Sherif Gamal, Asmaa A. Mandour, Gehad G. Mohamed, Said A. Salih, Dina A. Ahmed |
| 5 |
[GO] |
2023―Aug―01 |
In silico prediction of siRNA to silence the SARS-CoV-2 omicron variant targeting BA.4, BA.5, BQ.1, BQ1.1. and XBB: an alternative to traditional therapeutics |
Rahatul Islam, Asif Shahriar, Nour Fatema, Muhammad Ramiz Uddin, Mrityunjoy Acharjee, Md Mukhlesur Rahman Shepon, et al. (+2) Avishek Sarkar, Khosnur Jahan Aurin |
| 6 |
[GO] |
2022―Jun―21 |
Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro) |
Soumya Gulab Katre, Alpana Jagdish Asnani, Kumar Pratyush, Nilima Gangadhar Sakharkar, Ashwini Gajanan Bhope, Kanchan Tekram Sawarkar, Vaibhav Santosh Nimbekar |
| 7 |
[GO] |
2022―Mrz―28 |
Immunogenicity and clinical features relating to BNT162b2 messenger RNA COVID-19 vaccine, Ad26.COV2.S and ChAdOx1 adenoviral vector COVID-19 vaccines: a systematic review of non-interventional studies |
Chinonyerem O. Iheanacho, Uchenna I. H. Eze |
| 8 |
[GO] |
2021―Okt―10 |
Computational guided identification of potential leads from Acacia pennata (L.) Willd. as inhibitors for cellular entry and viral replication of SARS-CoV-2 |
James H. Zothantluanga, Neelutpal Gogoi, Anshul Shakya, Dipak Chetia, H. Lalthanzara |
| 9 |
[GO] |
2021―Sep―06 |
Computational approach towards the design of artemisinin-thymoquinone hybrids against main protease of SARS-COV-2 |
Victor Moreira de Oliveira, Matheus Nunes da Rocha, Emanuel Paula Magalhães, Francisco Rogênio da Silva Mendes, Márcia Machado Marinho, Ramon Róseo Paula Pessoa Bezerra de Menezes, et al. (+4) Tiago Lima Sampaio, Hélcio Silva dos Santos, Alice Maria Costa Martins, Emmanuel Silva Marinho |
| 10 |
[GO] |
2021―Aug―10 |
Flavonoid compounds of buah merah (Pandanus conoideus Lamk) as a potent SARS-CoV-2 main protease inhibitor: in silico approach |
Abd. Kakhar Umar |
| 11 |
[GO] |
2021―Jun―15 |
Virtual screenings of the bioactive constituents of tea, prickly chaff, catechu, lemon, black pepper, and synthetic compounds with the main protease (Mpro) and human angiotensin-converting enzyme 2 (ACE 2) of SARS-CoV-2 |
Nazim Uddin Emon, Md. Munsur Alam, Irin Akter, Saima Akhter, Anjuman Ara Sneha, Md. Irtiza, et al. (+4) Marufa Afroj, Arifa Munni, Masruba Hossen Chowdhury, Summiya Hossain |
| 12 |
[GO] |
2021―Jun―12 |
Substantial effect of phytochemical constituents against the pandemic disease influenza-a review |
A. Brindha Devi, R. Sarala |
| 13 |
[GO] |
2021―Jun―11 |
A comprehensive review on global contributions and recognition of pharmacy professionals amidst COVID-19 pandemic: moving from present to future |
Saad Ahmed Sami, Kay Kay Shain Marma, Agnila Chakraborty, Tandra Singha, Ahmed Rakib, Md. Giash Uddin, et al. (+2) Mohammed Kamrul Hossain, S. M. Naim Uddin |
| 14 |
[GO] |
2021―Jun―02 |
Potent phytochemicals against COVID-19 infection from phyto-materials used as antivirals in complementary medicines: a review |
C. S. Sharanya, A. Sabu, M. Haridas |
| 15 |
[GO] |
2021―Apr―09 |
Present and future treatment strategies for coronavirus disease 2019 |
Engy Elekhnawy, Amal Abo Kamar, Fatma Sonbol |
| 16 |
[GO] |
2021―Mrz―24 |
Risk of SARS-CoV-2 infection and COVID-19 prognosis with the use of renin-angiotensin-aldosterone system (RAAS) inhibitors: a systematic review |
Chinonyerem O. Iheanacho, Valentine U. Odili, Uchenna I. H. Eze |
| 17 |
[GO] |
2021―Mrz―20 |
Ethnomedicinal herbs in African traditional medicine with potential activity for the prevention, treatment, and management of coronavirus disease 2019 |
Olutayo Ademola Adeleye, Mbang Nyong Femi-Oyewo, Oluyemisi Adebowale Bamiro, Lateef Gbenga Bakre, Akinyinka Alabi, Joseph Senu Ashidi, et al. (+3) Olalekan Adeyinka Balogun-Agbaje, Oluwakemi Mary Hassan, Gbemisola Fakoya |
| 18 |
[GO] |
2021―Mrz―17 |
Therapeutic role of corticosteroids in COVID-19: a systematic review of registered clinical trials |
Reshma Raju, Prajith V., Pratheeksha Sojan Biatris, Sam Johnson Udaya Chander J. |
| 19 |
[GO] |
2021―Jan―09 |
Compounds of Citrus medica and Zingiber officinale for COVID-19 inhibition: in silico evidence for cues from Ayurveda |
M. Haridas, Vijith Sasidhar, Prajeesh Nath, J. Abhithaj, A. Sabu, P. Rammanohar |
| 20 |
[GO] |
2020―Nov―17 |
COVID-19 pandemic crisis-a complete outline of SARS-CoV-2 |
Sana Saffiruddin Shaikh, Anooja P. Jose, Disha Anil Nerkar, Midhuna Vijaykumar KV, Saquib Khaleel Shaikh |
| 21 |
[GO] |
2020―Okt―16 |
Activity of phytochemical constituents of Curcuma longa (turmeric) and Andrographis paniculata against coronavirus (COVID-19): an in silico approach |
Kalirajan Rajagopal, Potlapati Varakumar, Aparma Baliwada, Gowramma Byran |
